Last updated: May 04, 2026

Application No. 18/048,148

IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS

Final Rejection

Filed

Oct 20, 2022

Priority

Dec 30, 2015 — SE 1551723-8 +3 more

Examiner

DEVI, SARVAMANGALA

Art Unit

1645

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Minervax Aps

OA Round

4 (Final)

Interview Optional

— +54.7% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 66% grant rate with +54.7% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 862 resolved cases, 2023–2026

Examiner Intelligence

DEVI, SARVAMANGALA View full profile →

Grants 66% — above average

Career Allowance Rate

568 granted / 862 resolved

+5.9% vs TC avg

Strong +55% interview lift

Without

With

+54.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

49 currently pending

Career history

911

Total Applications

across all art units

Statute-Specific Performance

§101

0.5%

-39.5% vs TC avg

§103

19.1%

-20.9% vs TC avg

§102

17.0%

-23.0% vs TC avg

§112

17.7%

-22.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 862 resolved cases

Prosecution Timeline

Show 5 earlier events

Jan 17, 2025

Response after Non-Final Action

Feb 21, 2025

Request for Continued Examination

Feb 24, 2025

Response after Non-Final Action

Sep 01, 2025

Non-Final Rejection

Dec 02, 2025

Examiner Interview Summary

Dec 02, 2025

Applicant Interview (Telephonic)

Dec 22, 2025

Response Filed

Feb 07, 2026

Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/323,235

Patent 12594311

LACTOBACILLUS PLANTARUM PDG8 AND USE IN TREATING CARDIOVASCULAR DISEASES

2y 10m to grant Granted Apr 07, 2026

18/641,696

Patent 12569521

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS

1y 10m to grant Granted Mar 10, 2026

17/799,340

Patent 12495801

BACILLUS SUBTILIS JCK-1398 STRAIN INDUCING RESISTANCE IN VARIOUS PLANTS, AND COMPOSITION AND METHOD FOR CONTROLLING PINE WILT DISEASE BY USING SAME

3y 0m to grant Granted Dec 16, 2025

18/329,701

Patent 12485164

MENINGOCOCCUS VACCINES

2y 6m to grant Granted Dec 02, 2025

18/334,392

Patent 12472139

METHOD FOR MAINTAINING SKIN CORNEUM LAYER COMPLETENESS, PROMOTING HYALURONIC ACID PRODUCTION, IMPROVING SKIN CELL MITOCHONDRION ACTIVITY AND/ OR PROMOTING SKIN CELL PROLIFERATION BY USING BACTERIAL LYSATE OF HALOBACILLUS TRUEPERI TCI66207

2y 5m to grant Granted Nov 18, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6

Expected OA Rounds

66%

Grant Probability

99%

With Interview (+54.7%)

3y 4m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 862 resolved cases by this examiner. Grant probability derived from career allowance rate.